Top 5 Bill & Melinda Gates Foundation Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| BNTX | BIONTECH SE | 40.59% | 148.7K | $17.7M | +0.00%(+0) | — | 2024-09-30 | |
| VIR | VIR BIOTECHNOLOGY INC | 26.84% | 1.56M | $11.7M | +0.00%(+0) | — | 2024-09-30 | |
| EXAI | EXSCIENTIA | 17.85% | 1.59M | $7.8M | +0.00%(+0) | — | 2024-09-30 | |
| CVAC | CUREVAC N V | 10.6% | 1.57M | $4.6M | -1.80%(-28.77K) | — | 2024-09-30 | |
| BFLY | BUTTERFLY NETWORK INC | 4.11% | 1.01M | $1.8M | +0.00%(+0) | — | 2024-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Bill & Melinda Gates Foundation reports $43.50M in US-listed equity holdings across 5 positions in its most recent 13F filing. Its largest disclosed positions are BNTX (40.6%), VIR (26.8%) and EXAI (17.9%). Figures reflect the Q3 2024 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Bill & Melinda Gates Foundation, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Bill & Melinda Gates Foundation’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1663801). View Bill & Melinda Gates Foundation’s 13F filings on SEC